Pharming B.V.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Pharming B.V.
Live alerts from global media, monitored by Business Radar
2025-01-16 (mena.nl)
Biotech on the move: signs of recovery, larger financing rounds, maturing of the European sector and trends in focus areas -
The biotech sector has faced a number of challenges over the past few years, both for the private and public markets. This editorial special reflects on the developments. The past few years have been challenging years for the biotech sector, both in Europe and the United States. There was a lot of capital available until 2021 […]
Read more
2025-01-16 (mena.nl)
Biotech on the move: signs of recovery, larger financing rounds, maturing of the European sector and trends in focus areas -
The biotech sector has faced a number of challenges over the past few years, both for the private and public markets. This editorial special reflects on the developments. The past few years have been challenging years for the biotech sector, both in Europe and the United States. There was a lot of capital available until 2021 […]
Read more
2024-12-21 (iex.nl)
bammie
IEX.nl is the investor platform in the Netherlands. Stay up to date with all relevant information about shares and other investment products. Investing - Price - Shares - Discussion.
Read more
2019-03-07 (iex.nl)
BeursToday: Sluggish
Red rates. Boskalis and Pharming figures, Philips takeover, AF-KLM advice, Tom2 and ECB interest rate decision.
Read more
2019-03-07 (iex.nl)
BeursToday: Sluggish
Red rates. Boskalis and Pharming figures, Philips takeover, AF-KLM advice, Tom2 and ECB interest rate decision.
Read more
2019-03-07 (iex.nl)
BeursToday: Sluggish
Red rates. Boskalis and Pharming figures, Philips takeover, AF-KLM advice, Tom2 and ECB interest rate decision.
Read more
2019-03-07 (iex.nl)
BeursToday: Sluggish
Red rates. Boskalis and Pharming figures, Philips takeover, AF-KLM advice, Tom2 and ECB interest rate decision.
Read more
2019-03-07 (iex.nl)
BeursToday: Sluggish
Red rates. Boskalis and Pharming figures, Philips takeover, AF-KLM advice, Tom2 and ECB interest rate decision.
Read more
2018-11-05 (telegraaf.nl)
'Pharming is an interesting takeover target' | Financial | .nl
Biotechnology company Pharming is interesting for a takeover by a major pharmaceutical company, just like several other companies in the industry. This is what Stifel analysts write.
Read more